sumatriptan has been researched along with Anti-MuSK Myasthenia Gravis in 1 studies
Sumatriptan: A serotonin agonist that acts selectively at 5HT1 receptors. It is used in the treatment of MIGRAINE DISORDERS.
sumatriptan : A sulfonamide that consists of N,N-dimethyltryptamine bearing an additional (N-methylsulfamoyl)methyl substituent at position 5. Selective agonist for a vascular 5-HT1 receptor subtype (probably a member of the 5-HT1D family). Used (in the form of its succinate salt) for the acute treatment of migraine with or without aura in adults.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Dihydroergotamine mesylate was also abortive in the few instances when the headache worsened." | 1.30 | Successful treatment of headache related to intravenous immunoglobulin with antimigraine medications. ( Finkel, AG; Howard, JF; Mann, JD, 1998) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Finkel, AG | 1 |
| Howard, JF | 1 |
| Mann, JD | 1 |
1 other study available for sumatriptan and Anti-MuSK Myasthenia Gravis
| Article | Year |
|---|---|
Successful treatment of headache related to intravenous immunoglobulin with antimigraine medications.
Topics: Adult; Analgesics, Non-Narcotic; Dihydroergotamine; Female; Headache; Humans; Immunoglobulins, Intra | 1998 |